Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NN1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,699
Award facts
- Contract value 100% obligated
- $44,698.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,698.52 to AmerSourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This firm fixed-price contract, which carries no set-aside designation, was competitively awarded on January 29, 2026, with an ultimate completion date of January 30, 2026. The pharmaceutical product will be performed and delivered from AmerSourceBergen's location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., doing business as AmerSourceBergen, a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports critical federal healthcare missions including the Defense Health Agency, U.S. Coast Guard, and other government medical systems. Ozempic, a diabetes medication included in AmerSourceBergen's extensive portfolio of pharmaceutical deliveries, represents the type of specialty therapeutic products regularly procured through this strategic contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F9NN1?
SPE2DR26F9NN1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9NN1 worth?
The government has obligated $44,699 on SPE2DR26F9NN1.
Is contract SPE2DR26F9NN1 an order under another contract?
Yes. SPE2DR26F9NN1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NN1 competed?
The extent of competition for SPE2DR26F9NN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award